Page 26 - Synlogic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Synlogic Outlines Upcoming Clinical Milestones - Clinical proof of concept data in 2021 anticipated across multiple programs - News provided by Share this article CAMBRIDGE, Mass., Jan. 11, 2021 /PRNewswire/ -- Synlogic, Inc. ( Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today outlined significant clinical milestones for 2021 and provided an overview of recent progress. "With three programs in clinical trials, multiple proof of concept opportunities, and a preclinical portfolio advancing rapidly towards the clinic, Synlogic i...

Share this article Share this article ResearchAndMarkets.com's offering. The report gives insights into the transformational microbiome landscape. It is a rigorous assessment of the industry trends supported by detailed segmentation across publications, grants, clinical trials, and startup funding activity. The dataset behind the report is based on real world evidence that will drive actionable business insights. Follow trends over the years captured across publications, grants, clinical trials, and startup funding activity to power data driven marketing campaigns to fund raising to investo...